Galapagos Says Brus, Crucell Chief, Resigns From Board

Galapagos NV (GLPG) said Crucell NV Chief Executive Officer Ronald Brus resigned from the Belgian drug developer’s board of directors because of corporate policies at Johnson & Johnson (JNJ), according to a statement on its website.

To contact the editor responsible for this story: John Martens at jmartens1@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.